found that patients with high CKS2 expression in lung adenocarcinoma were more likely to relapse than those with low CKS2 expression, and overexpression of CKS2 would worsen the prognosis of patients with stage I-III invasive non-mucinous lung adenocarcinoma (78). This evidence concerns the gene CKS2 and lung adenocarcinoma.